Document is current
Any future updates will be listed below
-
Authors
Okusaka, Takuji https://orcid.org/0000-0003-1729-807X
Furuse, Junji
- License Information
-
More Information
Article History
Received: 28 December 2019
Accepted: 7 January 2020
First Online: 29 January 2020
Compliance with ethical standards
:
: Takuji Okusaka has received research funding from Novartis Pharma, Eli Lilly Japan, AstraZeneca, Chugai Pharmaceutical, Eisai, and Bristol-Myers. Junji Furuse has received honorarium from Eisai, Bayer Yakuhin, Taiho Pharmaceutical, Fujifilm, Astellas Pharma, Yakult Honsha, Ono Pharmaceutical, Shire, Chugai Pharma, Novartis, Teijin pharma, and research funding from Ono Pharmaceutical, MSD, J-Pharma, Taiho Pharmaceutical, Sumitomo Dainippon, Yakult Honsha, and AstraZeneca.
